Cholinergic drugs ameliorate endothelial dysfunction by decreasing O-GlcNAcylation via M3 AChR-AMPK-ER stress signaling

Life Sciences
Yan-Ling CuiWei-Jin Zang

Abstract

Obesity is associated with increased cardiovascular morbidity and mortality. It is accompanied by augmented O-linked β-N-acetylglucosamine (O-GlcNAc) modification of proteins via increasing hexosamine biosynthetic pathway (HBP) flux. However, the changes and regulation of the O-GlcNAc levels induced by obesity are unclear. High fat diet (HFD) model was induced obesity in mice with or without the cholinergic drug pyridostigmine (PYR, 3 mg/kg/d) for 22 weeks and in vitro human umbilical vein endothelial cells (HUVECs) was treated with high glucose (HG, 30 mM) with or without acetylcholine (ACh). PYR significantly reduced body weight, blood glucose, and O-GlcNAcylation levels and attenuated vascular endothelial cells detachment in HFD-fed mice. HG addition induced endoplasmic reticulum (ER) stress and increased O-GlcNAcylation levels and apoptosis in HUVECs in a time-dependent manner. Additionally, HG decreased levels of phosphorylated AMP-activated protein kinase (AMPK). Interestingly, ACh significantly blocked damage to HUVECs induced by HG. Furthermore, the effects of ACh on HG-induced ER stress, O-GlcNAcylation, and apoptosis were prevented by treating HUVECs with 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP, a sele...Continue Reading

References

May 13, 2004·The Journal of Biological Chemistry·Natasha E ZacharaGerald W Hart
Sep 24, 2004·Annals of Internal Medicine·Elizabeth SelvinSherita Hill Golden
Feb 25, 2006·Human Molecular Genetics·Ting-Ting HuangCharles J Epstein
Oct 18, 2007·Molecular BioSystems·Wagner B Dias, Gerald W Hart
Jun 10, 2008·Journal of Molecular and Cellular Cardiology·Gladys A NgohSteven P Jones
Nov 26, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Boglarka LaczyJohn C Chatham
Aug 4, 2009·Biochimica Et Biophysica Acta·John A HanoverDona C Love
Sep 8, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Gladys A NgohSteven P Jones
May 19, 2011·International Journal of Obesity : Journal of the International Association for the Study of Obesity·K Rooney, S E Ozanne
Oct 3, 2012·PloS One·Sebastiano BanniPaolo Follesa
Feb 22, 2013·Journal of Hypertension·Andreas M BeyerKamal Rahmouni
Mar 2, 2013·Current Pharmaceutical Design·Teresa Vanessa FiorentinoFranco Folli
Jan 30, 2014·Clinical and Experimental Pharmacology & Physiology·Fangfang QinWeijin Zang
Aug 19, 2014·IUBMB Life·Stefania LennaMaria Trojanowska
Nov 18, 2014·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Lei SunJun Zhou
Aug 25, 2015·Nutrition & Diabetes·M KozakovaE Ferrannini
Mar 26, 2016·Pharmacology & Therapeutics·Yingmei Zhang, Jun Ren
Jun 15, 2016·Hypertension·Kyungjoon LimGeoffrey A Head
Jul 2, 2017·Clinical Science·John J Reho, Kamal Rahmouni
Mar 15, 2018·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Shuyi WangJun Ren

❮ Previous
Next ❯

Citations

Nov 8, 2020·Cell Stress & Chaperones·Yang LiuShi-Ze Li
Mar 24, 2020·International Immunopharmacology·Ignaz Wessler, Charles James Kirkpatrick
Feb 24, 2021·Nature Reviews. Cardiology·Jun RenYingmei Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis